Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment.
Hideyuki MasuiKenji KawadaYoshiro ItataniHideyo HiraiYuki NakanishiYoshiyuki KiyasuKeita HanadaMichio OkamotoWataru HirataYasuyo NishikawaNaoko SugimotoTakuya TamuraYoshiharu SakaiKazutaka ObamaPublished in: British journal of cancer (2024)
Dual blockade of CCR1 and CXCR2 pathways in myeloid cells could be an effective therapy against colorectal cancer.